United Kingdom · Question · Written question
UIN 35641
Cancer: Medical Treatments
Original
Introduced
19 July 2021
Last action
27 July 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
27 July 2021
Summary
To ask the Secretary of State for Health and Social Care, whether he has had discussions with relevant stakeholders on the potential merits of emerging treatments from AstraZeneca for ovarian and kidney cancer being made available through the NHS.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 July 2021
Written question
To ask the Secretary of State for Health and Social Care, whether he has had discussions with relevant stakeholders on the potential merits of emerging treatments from AstraZeneca for ovarian and kidney cancer being made available through the NHS.
Source: Commons
27 July 2021
Answer
Ministers and officials regularly discuss emerging treatments with a range of organisations.The National Institute for Health and Care Excellence (NICE) is the independent body which makes evidence-based recommendations for the National Health Service on ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-07-19/35641
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1347973
- uk · wq-1347973 · source updated 27 July 2021